{"product_id":"tesamorelin","title":"Tesamorelin","description":"\u003cp\u003eTesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH), clinically approved for reducing excess visceral adipose tissue in HIV-associated lipodystrophy. It binds pituitary GHRH receptors to stimulate the natural, pulsatile release of growth hormone and subsequent IGF-1 production. Research is notable for its selectivity toward visceral (deep abdominal) fat: randomized trials demonstrate reductions in visceral adipose tissue of roughly 15-18% over 26 weeks, alongside decreased hepatic (liver) fat and improved triglyceride profiles, without significant loss of subcutaneous fat. Studies also show preserved glucose tolerance relative to direct GH administration, plus measurable gains in body composition and metabolic markers. Emerging research explores Tesamorelin's effects on cognition and liver health given its GH\/IGF-1-mediated pathway. Its targeted action on visceral fat and favorable metabolic profile make Tesamorelin a widely studied model compound in body-composition, metabolic, and hepatic-fat research.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eFor laboratory and research use only. Not for human consumption.\u003c\/em\u003e\u003c\/p\u003e","brand":"Olympix Bioscience","offers":[{"title":"10mg","offer_id":48082998263973,"sku":"VG-TESA-10MG","price":129.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/7779\/7285\/files\/IMG-0403.png?v=1785736419","url":"https:\/\/olympixbiolabs.com\/products\/tesamorelin","provider":"Prime Peptides","version":"1.0","type":"link"}